Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Exact Sciences Corp (EXAS)
since 2001 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Exact Sciences Corp.
Table 2 shows the detailed insider transactions.
This company's CIK number is 1124140.
Total stock buying since 2001: $1,792,411.
Total stock sales since 2001: $327,519,821.
Total stock option exercises since 2001: $31,007,777.
Table 3. Detailed insider trading at Exact Sciences Corp (EXAS)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2025-08-13 | Doyle James Edward | Sale | 1,485 | 42.02 | 62,399 |
| 2025-08-05 | Baranick Brian (EVP, GM, Precision Oncology) | Option Ex | 5,350 | .00 | 0 |
| 2025-08-05 | Orville Jacob A (EVP, GM, Screening) | Option Ex | 5,350 | .00 | 0 |
| 2025-06-13 | Zanotti Katherine S | Sale | 3,207 | 53.20 | 170,612 |
| 2025-04-15 | Bloomer Aaron (EVP, Chief Financial Officer) | Option Ex | 24,460 | .00 | 0 |
| 2025-03-07 | Conroy Kevin T (President and CEO) | Option Ex | 66,723 | 22.38 | 1,493,260 |
| 2025-02-28 | Herriott James (SVP, General Counsel & Sec) | Option Ex | 4,265 | .00 | 0 |
| 2025-02-28 | Conroy Kevin T (President and CEO) | Option Ex | 40,310 | .00 | 0 |
| 2025-02-25 | Herriott James (SVP, General Counsel & Sec) | Option Ex | 1,647 | .00 | 0 |
| 2025-02-25 | Baranick Brian (EVP, GM, Precision Oncology) | Option Ex | 3,954 | .00 | 0 |
| 2025-02-25 | Condella Sarah (EVP, Human Resources) | Option Ex | 3,954 | .00 | 0 |
| 2025-02-25 | Conroy Kevin T (President and CEO) | Option Ex | 13,180 | .00 | 0 |
| 2025-02-25 | Orville Jacob A (EVP, GM, Screening) | Option Ex | 3,954 | .00 | 0 |
| 2025-02-19 | Herriott James (SVP, General Counsel & Sec) | Option Ex | 865 | .00 | 0 |
| 2025-02-19 | Baranick Brian (EVP, GM, Precision Oncology) | Option Ex | 1,729 | .00 | 0 |
| 2025-02-19 | Condella Sarah (EVP, Human Resources) | Option Ex | 2,248 | .00 | 0 |
| 2025-02-19 | Conroy Kevin T (President and CEO) | Option Ex | 10,374 | .00 | 0 |
| 2025-02-19 | Orville Jacob A (EVP, GM, Screening) | Option Ex | 2,248 | .00 | 0 |
| 2025-02-19 | Coward D Scott | Option Ex | 2,248 | .00 | 0 |
| 2024-11-13 | Conroy Kevin T (President and CEO) | Buy | 19,500 | 51.35 | 1,001,325 |
| 2024-10-08 | Baranick Brian (EVP, GM, Precision Oncology) | Sale | 929 | 70.00 | 65,030 |
| 2024-09-18 | Baranick Brian (EVP, GM, Precision Oncology) | Sale | 929 | 70.00 | 65,030 |
| 2024-08-05 | Baranick Brian (EVP, GM, Precision Oncology) | Option Ex | 2,712 | .00 | 0 |
| 2024-05-01 | Herriott James (SVP, General Counsel & Sec) | Sale | 30 | 60.15 | 1,804 |
| 2024-05-01 | Baranick Brian (EVP, GM., Precision Oncology) | Sale | 110 | 60.15 | 6,616 |
| 2024-05-01 | Condella Sarah (EVP, Human Resources) | Sale | 102 | 60.15 | 6,135 |
| 2024-05-01 | Elliott Jeffrey Thomas (Chief Financial Officer) | Sale | 136 | 60.15 | 8,180 |
| 2024-05-01 | Cunningham Everett (Chief Commercial Officer) | Sale | 136 | 60.15 | 8,180 |
| 2024-05-01 | Conroy Kevin T (President and CEO) | Sale | 1,155 | 60.15 | 69,473 |
| 2024-05-01 | Orville Jacob A (General Manager, Screening) | Sale | 102 | 60.15 | 6,135 |
| 2024-05-01 | Coward D Scott | Sale | 67 | 60.15 | 4,030 |
| 2024-04-02 | Baranick Brian (EVP, GM., Precision Oncology) | Sale | 924 | 79.43 | 73,393 |
| 2024-04-01 | Condella Sarah (EVP, Human Resources) | Sale | 2,000 | 70.00 | 140,000 |
| 2024-03-28 | Condella Sarah (EVP, Human Resources) | Sale | 2,000 | 70.00 | 140,000 |
| 2024-03-01 | Herriott James (General Counsel) | Sale | 862 | 59.32 | 51,133 |
| 2024-03-01 | Baranick Brian (Gen. Mgr., Precision Oncology) | Sale | 2,323 | 59.32 | 137,800 |
| 2024-03-01 | Condella Sarah (EVP, Human Resources) | Sale | 1,724 | 59.32 | 102,267 |
| 2024-03-01 | Elliott Jeffrey Thomas (Chief Financial Officer) | Sale | 2,412 | 59.32 | 143,079 |
| 2024-03-01 | Doyle James Edward (Director) | Sale | 2,000 | 57.50 | 115,000 |
| 2024-03-01 | Cunningham Everett (Chief Commercial Officer) | Sale | 2,412 | 59.32 | 143,079 |
| 2024-03-01 | Conroy Kevin T (President and CEO) | Sale | 8,271 | 59.32 | 490,635 |
| 2024-03-01 | Orville Jacob A (General Manager, Screening) | Sale | 2,154 | 59.32 | 127,775 |
| 2024-03-01 | Levangie Daniel J (Director) | Sale | 5,000 | 57.50 | 287,500 |
| 2024-02-29 | Herriott James (General Counsel) | Option Ex | 1,890 | .00 | 0 |
| 2024-02-29 | Baranick Brian (Gen. Mgr., Precision Oncology) | Option Ex | 4,724 | .00 | 0 |
| 2024-02-29 | Condella Sarah (EVP, Human Resources) | Option Ex | 3,779 | .00 | 0 |
| 2024-02-29 | Elliott Jeffrey Thomas (Chief Financial Officer) | Option Ex | 5,291 | .00 | 0 |
| 2024-02-29 | Cunningham Everett (Chief Commercial Officer) | Option Ex | 5,291 | .00 | 0 |
| 2024-02-29 | Conroy Kevin T (President and CEO) | Option Ex | 18,143 | .00 | 0 |
| 2024-02-29 | Orville Jacob A (General Manager, Screening) | Option Ex | 4,724 | .00 | 0 |
| 2024-02-27 | Herriott James (General Counsel) | Sale | 784 | 56.89 | 44,601 |
| 2024-02-27 | Baranick Brian (Gen. Mgr., Precision Oncology) | Sale | 2,027 | 56.89 | 115,316 |
| 2024-02-27 | Condella Sarah (EVP, Human Resources) | Sale | 1,880 | 56.89 | 106,953 |
| 2024-02-27 | Elliott Jeffrey Thomas (Chief Financial Officer) | Sale | 2,710 | 56.89 | 154,171 |
| 2024-02-27 | Cunningham Everett (Chief Commercial Officer) | Sale | 3,648 | 56.89 | 207,534 |
| 2024-02-27 | Conroy Kevin T (President and CEO) | Sale | 6,263 | 56.89 | 356,302 |
| 2024-02-27 | Orville Jacob A (General Manager, Screening) | Sale | 1,879 | 56.89 | 106,896 |
| 2024-02-26 | Herriott James (General Counsel) | Option Ex | 1,648 | .00 | 0 |
| 2024-02-26 | Baranick Brian (Gen. Mgr., Precision Oncology) | Option Ex | 3,954 | .00 | 0 |
| 2024-02-26 | Condella Sarah (EVP, Human Resources) | Option Ex | 3,954 | .00 | 0 |
| 2024-02-26 | Elliott Jeffrey Thomas (Chief Financial Officer) | Option Ex | 5,701 | .00 | 0 |
| 2024-02-26 | Cunningham Everett (Chief Commercial Officer) | Option Ex | 7,678 | .00 | 0 |
| 2024-02-26 | Conroy Kevin T (President and CEO) | Option Ex | 13,181 | .00 | 0 |
| 2024-02-26 | Orville Jacob A (General Manager, Screening) | Option Ex | 3,954 | .00 | 0 |
| 2024-02-23 | Condella Sarah (EVP, Human Resources) | Sale | 1,021 | 59.72 | 60,974 |
| 2024-02-23 | Conroy Kevin T (President and CEO) | Option Ex | 102,837 | 13.96 | 1,435,604 |
| 2024-02-22 | Herriott James (General Counsel) | Sale | 291 | 59.78 | 17,395 |
| 2024-02-22 | Baranick Brian (Gen. Mgr., Precision Oncology) | Sale | 1,093 | 59.78 | 65,339 |
| 2024-02-22 | Condella Sarah (EVP, Human Resources) | Sale | 1,013 | 59.78 | 60,557 |
| 2024-02-22 | Elliott Jeffrey Thomas (Chief Financial Officer) | Sale | 1,351 | 59.78 | 80,762 |
| 2024-02-22 | Cunningham Everett (Chief Commercial Officer) | Sale | 1,350 | 59.78 | 80,703 |
| 2024-02-22 | Conroy Kevin T (President and CEO) | Sale | 11,565 | 59.78 | 691,355 |
| 2024-02-22 | Orville Jacob A (General Manager, Screening) | Sale | 1,013 | 59.78 | 60,557 |
| 2024-02-22 | Coward D Scott (Director) | Sale | 663 | 59.78 | 39,634 |
| 2024-02-21 | Herriott James (General Counsel) | Sale | 415 | 61.50 | 25,522 |
| 2024-02-21 | Baranick Brian (Gen. Mgr., Precision Oncology) | Sale | 895 | 61.50 | 55,042 |
| 2024-02-21 | Condella Sarah (EVP, Human Resources) | Sale | 1,079 | 61.50 | 66,358 |
| 2024-02-21 | Elliott Jeffrey Thomas (Chief Financial Officer) | Sale | 1,493 | 61.50 | 91,819 |
| 2024-02-21 | Conroy Kevin T (President and CEO) | Sale | 4,975 | 61.50 | 305,962 |
| 2024-02-21 | Orville Jacob A (General Manager, Screening) | Sale | 1,078 | 61.50 | 66,297 |
| 2024-02-21 | Coward D Scott (Director) | Sale | 706 | 61.50 | 43,419 |
| 2024-02-20 | Herriott James (General Counsel) | Option Ex | 864 | .00 | 0 |
| 2024-02-20 | Baranick Brian (Gen. Mgr., Precision Oncology) | Option Ex | 1,729 | .00 | 0 |
| 2024-02-20 | Condella Sarah (EVP, Human Resources) | Option Ex | 2,248 | .00 | 0 |
| 2024-02-20 | Elliott Jeffrey Thomas (Chief Financial Officer) | Option Ex | 3,112 | .00 | 0 |
| 2024-02-20 | Conroy Kevin T (President and CEO) | Option Ex | 10,374 | .00 | 0 |
| 2024-02-20 | Orville Jacob A (General Manager, Screening) | Option Ex | 2,248 | .00 | 0 |
| 2024-02-20 | Coward D Scott (Director) | Option Ex | 2,248 | .00 | 0 |
| 2024-02-15 | Herriott James (General Counsel) | Sale | 421 | 61.43 | 25,862 |
| 2024-02-15 | Condella Sarah (EVP, Human Resources) | Sale | 965 | 61.43 | 59,279 |
| 2024-02-15 | Conroy Kevin T (President and CEO) | Sale | 14,791 | 61.43 | 908,611 |
| 2024-02-15 | Orville Jacob A (General Manager, Screening) | Sale | 966 | 61.43 | 59,341 |
| 2024-02-15 | Coward D Scott (Director) | Sale | 1,376 | 61.43 | 84,527 |
| 2024-02-14 | Herriott James (General Counsel) | Option Ex | 883 | .00 | 0 |
| 2024-02-14 | Condella Sarah (EVP, Human Resources) | Option Ex | 2,031 | .00 | 0 |
| 2024-02-14 | Conroy Kevin T (President and CEO) | Option Ex | 31,133 | .00 | 0 |
| 2024-02-14 | Orville Jacob A (General Manager, Screening) | Option Ex | 2,031 | .00 | 0 |
| 2024-02-14 | Coward D Scott (Director) | Option Ex | 3,972 | .00 | 0 |
| 2024-01-02 | Baranick Brian (Gen. Mgr., Precision Oncology) | Sale | 879 | 73.50 | 64,606 |
| 2024-01-02 | Condella Sarah (EVP, Human Resources) | Sale | 2,000 | 73.50 | 147,000 |
| 2023-12-14 | Condella Sarah (EVP, Human Resources) | Sale | 2,000 | 70.00 | 140,000 |
| 2023-10-12 | Cunningham Everett (Chief Commercial Officer) | Sale | 13,007 | 66.49 | 864,835 |
| 2023-10-11 | Cunningham Everett (Chief Commercial Officer) | Option Ex | 27,504 | .00 | 0 |
| 2023-09-01 | Condella Sarah (EVP, Human Resources) | Sale | 4,500 | 84.36 | 379,620 |
| 2023-08-21 | Elliott Jeffrey Thomas (Chief Financial Officer) | Sale | 30,210 | 82.92 | 2,505,013 |
| 2023-08-07 | Baranick Brian (Gen. Mgr., Precision Oncology) | Sale | 1,350 | 85.04 | 114,804 |
| 2023-08-04 | Baranick Brian (Gen. Mgr., Precision Oncology) | Option Ex | 2,712 | .00 | 0 |
| 2023-07-27 | Doyle James Edward (Director) | Sale | 2,000 | 97.42 | 194,840 |
| 2023-07-19 | Herriott James (General Counsel) | Sale | 1,300 | 100.00 | 130,000 |
| 2023-05-26 | Doyle James Edward (Director) | Sale | 2,000 | 80.62 | 161,240 |
| 2023-05-10 | Herriott James (General Counsel) | Sale | 1,300 | 79.85 | 103,804 |
| 2023-05-10 | Condella Sarah (EVP, Human Resources) | Sale | 6,087 | 80.00 | 486,960 |
| 2023-05-10 | Orville Jacob A (General Manager, Screening) | Sale | 5,000 | 80.00 | 400,000 |
| 2023-05-01 | Condella Sarah (EVP, Human Resources) | Sale | 1,000 | 63.78 | 63,780 |
| 2023-04-03 | Condella Sarah (EVP, Human Resources) | Sale | 1,000 | 67.19 | 67,190 |
| 2023-03-03 | Orville Jacob A (General Manager, Screening) | Sale | 5,000 | 65.00 | 325,000 |
| 2023-03-01 | Condella Sarah (EVP, Human Resources) | Sale | 1,000 | 62.00 | 62,000 |
| 2023-03-01 | Cunningham Everett (Chief Commercial Officer) | Sale | 3,628 | 62.01 | 224,972 |
| 2023-02-28 | Herriott James (General Counsel) | Sale | 2,225 | 60.55 | 134,723 |
| 2023-02-28 | Baranick Brian (Gen. Mgr., Precision Oncology) | Sale | 1,932 | 61.12 | 118,083 |
| 2023-02-28 | Condella Sarah (EVP, Human Resources) | Sale | 2,924 | 61.12 | 178,714 |
| 2023-02-28 | Elliott Jeffrey Thomas (Chief Financial Officer) | Sale | 4,233 | 61.12 | 258,720 |
| 2023-02-28 | Conroy Kevin T (President and CEO) | Sale | 10,416 | 61.12 | 636,625 |
| 2023-02-28 | Orville Jacob A (General Manager, Screening) | Sale | 6,832 | 60.55 | 413,677 |
| 2023-02-28 | Coward D Scott (Director) | Sale | 4,153 | 61.12 | 253,831 |
| 2023-02-27 | Herriott James (General Counsel) | Option Ex | 1,887 | .00 | 0 |
| 2023-02-27 | Baranick Brian (Gen. Mgr., Precision Oncology) | Option Ex | 3,954 | .00 | 0 |
| 2023-02-27 | Condella Sarah (EVP, Human Resources) | Option Ex | 6,311 | .00 | 0 |
| 2023-02-27 | Elliott Jeffrey Thomas (Chief Financial Officer) | Option Ex | 9,137 | .00 | 0 |
| 2023-02-27 | Cunningham Everett (Chief Commercial Officer) | Option Ex | 7,677 | .00 | 0 |
| 2023-02-27 | Conroy Kevin T (President and CEO) | Option Ex | 22,492 | .00 | 0 |
| 2023-02-27 | Orville Jacob A (General Manager, Screening) | Option Ex | 3,954 | .00 | 0 |
| 2023-02-27 | Coward D Scott (Director) | Option Ex | 9,194 | .00 | 0 |
| 2023-02-22 | Herriott James (General Counsel) | Sale | 398 | 62.72 | 24,962 |
| 2023-02-22 | Baranick Brian (Gen. Mgr., Precision Oncology) | Sale | 838 | 62.72 | 52,559 |
| 2023-02-22 | Elliott Jeffrey Thomas (Chief Financial Officer) | Sale | 1,430 | 62.72 | 89,689 |
| 2023-02-22 | Conroy Kevin T (President and CEO) | Sale | 4,764 | 62.72 | 298,798 |
| 2023-02-22 | Orville Jacob A (General Manager, Screening) | Sale | 2,710 | 62.72 | 169,971 |
| 2023-02-22 | Coward D Scott (Director) | Sale | 1,007 | 62.72 | 63,159 |
| 2023-02-21 | Herriott James (General Counsel) | Option Ex | 865 | .00 | 0 |
| 2023-02-21 | Baranick Brian (Gen. Mgr., Precision Oncology) | Option Ex | 1,729 | .00 | 0 |
| 2023-02-21 | Elliott Jeffrey Thomas (Chief Financial Officer) | Option Ex | 3,112 | .00 | 0 |
| 2023-02-21 | Conroy Kevin T (President and CEO) | Option Ex | 10,374 | .00 | 0 |
| 2023-02-21 | Orville Jacob A (General Manager, Screening) | Option Ex | 5,897 | .00 | 0 |
| 2023-02-21 | Coward D Scott (Director) | Option Ex | 2,248 | .00 | 0 |
| 2023-02-16 | Condella Sarah (EVP, Human Resources) | Sale | 1,076 | 63.91 | 68,767 |
| 2023-02-15 | Herriott James (General Counsel) | Sale | 400 | 65.59 | 26,236 |
| 2023-02-15 | Condella Sarah (EVP, Human Resources) | Sale | 954 | 65.59 | 62,572 |
| 2023-02-15 | Elliott Jeffrey Thomas (Chief Financial Officer) | Sale | 1,866 | 65.59 | 122,390 |
| 2023-02-15 | Conroy Kevin T (President and CEO) | Sale | 14,617 | 65.59 | 958,729 |
Insider trading activities including stock purchases, stock sales, and option exercises
of EXAS listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Exact Sciences Corp (symbol EXAS,
CIK number 1124140) see
the Securities and Exchange Commission (SEC) website.